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For over 80 years now, Shigella dysenteriae  1 has been known to produce one 
of the most potent of the lethal microbial toxins. It was originally called Shiga 
toxin (after the discoverer of the organism, K. Shiga) and classified as a  neuro- 
toxin because it results in a  delayed-onset limb paralysis terminating in death 
when parenterally administered to sensitive animals (reviewed in reference  1). 
Shigella toxin is also cytotoxic to certain tissue culture cells, as well as enterotoxic 
(results in fluid secretion) when applied to intestinal mucosa (2-5).  Biochemical 
and immunological evidence indicate that the three biological activities are the 
properties of the same molecule (3, 5). Its role in the pathogenesis of shigellosis 
has always been controversial, in part because other species of the genus could 
not be shown to produce the same toxin. This argument is no longer valid, for 
both S. flexneri and S.  sonnei have been found to produce shigella toxin under 
appropriate  in vitro conditions, and convalescent patients develop an antibody 
that neutralizes the dysenteriae 1 toxin (6-8). Pathogenic bacteria of other genera 
have also been found to produce a  similar toxin that is neutralized by antibody 
to shigella toxin. These organisms include a variety ofE. coli serotypes including 
human  enteropathogenic  strains,  the  causative  strain  of human  hemorrhagic 
colitis (Escherichia  coli 0:155), the noninvasive rabbit pathogen RDEC-1, human 
Salmonella strains, and even Vibrio cholerae  (9-11).  The cross-reactive toxin has 
been dubbed  "Shiga-like toxin." Since these E.  coli strains do not produce the 
well-known LT or ST toxins and since a mutant strain of V. cholerae  deleted of 
the gene for the production of the ADP-ribosyl transferase enzyme subunit A of 
cholera toxin (12) causes diarrhea  in humans, the shigella (or Shiga-like) toxin 
may well be a critical virulence factor in diarrheal disease. 
Because  of these  observations,  there  is  great  interest  in  this toxin and  the 
immunologically related products of other organisms. Shigeila toxin has recently 
(9-15)  been  purified and  partially  characterized  by  several  laboratories.  The 
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toxin consists of two separate polypeptide chains, a larger A chain and a smaller 
B chain. These polypeptides associate noncovalently to form a complex consisting 
of one A  chain and multiple B chains, although the precise stoichiometry is not 
certain.  While it is known that the A  chain inhibits protein  synthesis in vitro, 
apparently by catalytically inactivating the eukaryotic 60S ribosomal subunit (16), 
the  presumed  function  of the  B  subunit  to  mediate  the  binding  of toxin  to 
glycoprotein  receptors  (17)  at  the  target  cell  surface  has  not  been  directly 
demonstrated.  In  fact,  isolated  shigella  toxin  B  chains  do  not  bind  to  toxin- 
sensitive cell lines (14, and our unpublished observations). 
In the present study, we report the characterization of shigella toxin obtained 
by a  rapid, high yield purificati6n scheme.  In addition, we present studies with 
subunit-specific, polyclonal and monoclonal toxin-neutralizing antibodies which 
indicate that the B subunit is involved in toxin binding to cell surface receptors. 
This method and the reagents developed should help to better define the nature 
of the Shiga-like toxin of E. coli, Salmonella sp., and V. cholerae. 
Materials and Methods 
Materials.  Casamino acids  and  Freund's complete and  incomplete adjuvants were 
obtained from Difco Laboratories, Detroit, MI. Blue Sepharose CL-6B, Sephadex G-25, 
cyanogen bromide-activated Sepharose  4B,  protein  A,  Polybuffer exchanger  94  and 
Polybuffer 96 were purchased from Pharmacia Fine Chemicals, Piscataway,  NJ. Bio-Gel 
P-60, all reagents for sodium dodecyl sulfate (SDS)  ~ polyacrylamide gel electrophoresis, 
and Zeta-Probe paper  were  from Bio-Rad Laboratories,  Richmond, CA.  Pristane was 
obtained from Aldrich Chemical Company, Milwaukee, WI. Chloramine T, Na metabi- 
sulfite, rabbit  hemoglobin, ovalbumin, human transferrin, and bovine serum albumin 
were obtained from Sigma Chemical Company, St. Louis, MO. Fixed Staphylococcus aureus 
(IgGsorb) was purchased from The Enzyme Center, Malden, MA, and dimethyl pimelim- 
idate (DMP) was from Pierce Chemical Company, Rockford, IL. NalZSI (17.4 Ci//~g) was 
purchased from New England Nuclear, Boston, MA. All tissue culture media were from 
Gibco Laboratories, Grand Island, NY. 
Bacterial  Strain  and Culture  Conditions.  S.  dysenteriae  1 strain 60R was used for all 
studies reported. This strain is a noninvasive, avirulent, toxigenic rough mutant originally 
isolated by Dubos and Geiger (18).  The culture medium used was a  modified syncase 
broth (19) containing 1% casamino acids,  0.004%  tryptophan, and 0.2% glucose.  This 
medium contained an optimal concentration of iron (~0.1 ~g Fe  ++÷ per ml) for maximal 
toxin production in culture (1). 
Toxin Purification.  A  1% overnight bacterial inoculum was added to the medium and 
the cultures were grown aerobically with shaking at 300 rpm at 37 °C. Bacterial cultures 
were harvested in early stationary growth (A600 =  3-3.5)  and chilled to  4°C  for the 
remainder of the isolation procedure. Cells were pelleted by centrifugation at  10,000  g 
for 10 min and washed twice by resuspension in  10 mM Tris-HCl, pH 7.4, followed by 
centrifugation. The final cell pellet was suspended in wash buffer to 1/50th of the original 
culture volume and lysed by sonication using a  Branson Sonifier (model  184;  Branson 
Sonic Power Co., Danbury, CT) until >95%  lysis was achieved, measured by following 
the absorbance at 600 nm. Unbroken cells were then pelleted by centrifugation for 20 
min at 5,000 g in a Sorvall GSA rotor (DuPont Instruments, Wilmington, DE). 
The crude cell lysate was applied at room temperature to a column (2.5  ×  50 cm) 
containing Cibacron Blue F3G-A coupled to Sepharose CL-6B (Blue Sepharose), equili- 
brated with 10 mM Tris-HCl, pH 7.4. The flow-through was continuously recycled for 
12 h, when the column was washed with 10 column volumes of 10 mM Tris-HCl, pH 7.4. 
I Abbreviations  used  in  this  paper:  DMP, dimethyl  pimelimidate;  SDS, sodium  dodecyl  sulfate; 
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Bound material was then eluted with the same buffer containing 0.5 M NaCI. Fractions 
from the salt elution containing protein were detected by absorbance, pooled, and dialyzed 
against 25 mM Tris-acetate, pH 8.3. The material was then applied to a column (0.9  × 
20 cm) of Polybuffer exchanger 94 equilibrated with 25 mM Tris-acetate, pH 8.3. Elution 
of bound material was initiated with a degassed solution of Polybuffer 96 diluted  1:13 in 
water and adjusted to pH 6.0 with acetic acid. Fractions of 1.5 ml were collected, the pH 
determined, and cytotoxin activity assayed in HeLa cells after adjustment of pH to 7.4. 
Fractions containing cytotoxin were pooled, transferred to a dialysis bag, and incubated 
with dry polyethylene glycol (Mr 20,000) at room temperature to reduce the volume to 2 
ml. The concentrated cytotoxin was then applied to a column (1.5 x  100 cm) of Bio-Gel 
P-60 equilibrated with 20 mM ammonium bicarbonate. Cytotoxin was eluted in the same 
buffer, and the toxin containing fractions were pooled and lyophilized. 
Separation of A and B Subunits.  Shigella toxin A and B subunits were separated by a 
modification of the l~spr°cedure of Lai. et al. (20).  100-200 t~g of purified toxin" containing 
tracer amounts  of  I-labeled toxin  were  dissolved  in  0.2  ml  of 5%  formic acid  and 
applied to a Bio-Gel P-60 column (0.9 ×  18 cm). Fractions of 0.4 ml were eluted with 5% 
formic acid at a  flow rate of 2  ml/h.  Fractions containing the A  and  B subunits  were 
identified  by SDS-polyacrylamide gel electrophoresis,  and  were separately pooled and 
lyophilized. To resuspend the lyophilized subunits, we initially solubilized them in 10 mM 
Tris-HCl, pH 7.4, containing 8  M urea. The solutions were then transferred to dialysis 
tubing and dialyzed against the same buffer. The concentration of urea in the dialysis 
buffer was gradually diluted to 0.8 M over 4 h by the addition of urea-free 10 mM Tris- 
HC1, pH 7.4. The subunits were then dialyzed against the latter buffer. 
Radioiodination.  Protein was radiolabeled with 12~I using a modification of the chlor- 
amine T  procedure (21).  One mCi of carrier-free Nat25I was added to 10-20 ~g of toxin 
in 150 #1 of 0.1  M sodium phosphate, pH 7.4.20 #1 of a 2.5 mg/ml solution of chloramine 
T  was  added  and,  after  a  20  s  incubation,  20  IA  of a  5  mg/ml  solution  of sodium 
metabisulfite was added. Rabbit hemoglobin (I 00 ~g) was added as a carrier protein and 
bound and unbound label were separated on a  10 ml Sephadex G-25 column. 
Protein Determinations.  For protein determinations we used the Bio-Rad assay kit II 
(Bio-Rad Laboratories) with bovine serum albumin as standard. 
Polyacrylamide Gel Electrophoresis.  Electrophoresis was performed in  15-cm slab gels, 
1.5  mm thick, The SDS gel system described by Dharmalingam and Goldberg (22) was 
used.  Gels containing  ~25I-labeled protein were dried and exposed at -70°C to Kodak 
XRP X-omat film with an intensifying screen. 
Cross-linking.  Protein samples were cross-linked with DMP using a modification of the 
procedure of Brew et al (23).  Protein solutions were dialyzed against 0.2 M triethanola- 
mine, pH 8.5. DMP-HCI was dissolved in 0.2 M triethanolamine buffer to a concentration 
of 10 mg/ml, and the pH was adjusted to 8.5.30 ~1 of protein solution containing up to 
10  t~g of protein and  6  ~1 of DMP  was incubated at  37°C  for  1 h.  The reaction was 
terminated by the addition of glycine to a final concentration of 0.2 M. 
Analysis of Amino Acid Composition.  Samples containing ~ 10 ~g of the purified toxin 
protein were hydrolyzed in 6 N HCI in vacuo for 24 h at 110°C and analyzed using a D- 
500 amino acid analyzer (Durrum Instrument, Sunnyvale, CA). No attempt was made to 
analyze for either tryptophan or cysteine. 
Development of Polyclonal Rabbit Antiserum  to Shigella Toxin.  To neutralize the lethal 
neurotoxin activity, purified shigella toxin was converted to a toxoid by formalin treat- 
ment. Samples of toxin containing  100 #g of protein were treated for 3 d at 37°C with 
0.1  M sodium phosphate, pH 8, containing 1% formalin. The protein was then dialyzed 
against  phosphate-buffered  saline  (PBS).  The  toxoid  contained  <1%  of the  original 
cytotoxin activity. Initially,  100 #g of toxoid protein in 0.5  ml PBS was mixed with an 
equal  volume of Freund's complete adjuvant and  injected  subcutaneously into  a  New 
Zealand White rabbit at four sites.  5 wk after the initial immunization a booster injection 
of 50 #g toxoid in Freund's incomplete adjuvant was administered. Identical booster doses 
were given at 5-wk intervals. Bleedings for antiserum were performed 8-10 d after each 
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Isolation of Anti-Subunit B Rabbit Antibodies.  Cyanogen bromide-activated Sepharose 
4B (0.2  g) was washed on a sintered glass filter with four 25-ml aliquots of 1 mM HCi. 
The  washed  gel  was  added  to  50  ~g of toxin  subunit  B  dissolved  in  0.1  M  sodium 
bicarbonate, pH  8.3, containing 0.5  M  NaCI. The suspension was placed on a  rocking 
platform and  incubated  at  4°C  overnight.  To  block  remaining active  groups on  the 
Sepharose,  the  gel  was transferred  to  5  ml  of 0.2  M  glycine, pH  8.0.  After a  second 
overnight incubation at 4 ° C, the gel was washed five times, alternately with 0.1 M acetate, 
pH 4.0, containing 0.5 M NaCI, and 0.1  M sodium bicarbonate, pH 8.3, containing 0.5 
M NaCI. The subunit B-Sepharose 4B gel (0.5 ml wet volume) was suspended in 0.1  M 
sodium bicarbonate, pH 8.3 and poured into a 0.5-cm diam column. 
To minimize nonspecific binding of the immune serum,  3 ml of nonimmune rabbit 
serum  was  applied  to  the  column of subunit  B-Sepharose  4B.  After passage  of the 
nonimmune serum,  0.5  ml  of rabbit antitoxin  serum  was applied  to the column. The 
immune serum was allowed to interact with the gel matrix for 1 h at room temperature. 
The column was then washed with 50 ml of 0.1  M sodium bicarbonate, pH 8.0, containing 
0.5 M NaCI.  To dissociate  anti-subunit B antibodies from the gel-protein complex, the 
column was washed with  50 mM glycine-HCl buffer, pH 2.7. The column effluent was 
collected in  0.5-ml fractions and immediately neutralized by the addition of Tris base. 
The  elution  of antitoxin  antibody  was  measured  by  the  ability  of the  fractions  to 
immunoprecipitate  1 ng of ~2~I-labeled shigeila  toxin  (~30,000  cpm).  Antibody-toxin 
complexes were immunoprecipitated using fixed protein A-positive Staphylococcus aureus 
by the procedure of Kessler (24). 
Production and Screening of  Monoclonal Antitoxin Antibodies.  4-8-wk-old female BALB/ 
c mice were injected subcutaneously with 20 ~g of toxoid in complete Freund's adjuvant. 
1 mo later they were boosted subcutaneously with 20 ~g of toxoid in incomplete Freund's 
adjuvant.  3 wk later, the mice were intravenously boosted with the same dose of toxoid 
in PBS via the tail vein.  4 d later mice were sacrificed by cervical dislocation and spleen 
cells were prepared and fused to P3x63Ag8.653 myeloma cells at a ratio of 2:1  by the 
procedure  of  Kohler  and  Milstein  (25).  Fused  cells  from  one  animal's  spleen  were 
distributed among five  24-well  plastic  trays containing BALB/c spleen cells as a  feeder 
layer.  After 2 wk in  culture,  supernatants were analyzed for toxin-specific  antibody by 
immunoprecipitation of ~25I-toxin. Strongly positive cultures were expanded and cloned 
twice by limiting dilution. Ascites fluid was prepared from stable hybridoma cell lines by 
injecting 5  x  106 cells intraperitoneally into BALB/c mice that had been primed 2 wk 
earlier by intraperitoneal injection of 0.5 ml of Pristane. 
Western Blot Analysis of Antibodies.  The subunit specificity  of the antitoxin antibodies 
was  analyzed  using  Western  blotting  (26).  Toxin  (20-50  ~g)  was  subjected  to  SDS- 
polyacrylamide gel electrophoresis in  15% acrylamide slab gels.  The dissociated protein 
subunits were then electrophoretically transferred (2 h at 300 mA) to a Zeta-Probe filter. 
The buffer used in the transfer was  15.6  mM Tris-120 mM glycine, pH 8.3.  The filter 
was then incubated for 16 h at 50°C in 0.1  M Tris-HCI, pH 7.4, 0.9% NaCI (Tris-saline) 
containing 10% bovine serum albumin (BSA). Next, the filter was incubated overnight at 
4°C with a  1:100 dilution of either hybridoma ascitic  fluid or rabbit  serum, and then 
washed twice by rocking for  10 rain  in  Tris-saline.  In the case  of two non-protein A- 
precipitating monoclonal antibodies,  5D2 and  5B2,  the filter  was incubated for2 h at 
room temperature with a 1  : 100 dilution of rabbit anti-mouse IgG serum and then washed 
for two 10-min periods with Tris-saline.  To visualize antibody bound to antigen, the blot 
was incubated for 2 h at room temperature in Tris-saline containing 5% BSA and 5 X 10 ~ 
cpm/ml of ~SI-labeled  protein A. After this incubation, the filter was washed extensively 
in Tris-saline, air-dried, wrapped in plastic  wrap, and developed by autoradiography. 
Assay for Toxin and Antitoxin Activities.  Cytotoxin was assessed  with a cytolethal assay 
using HeLa cells in  monolayer culture in  microtiter plates as previously described (27). 
Anticytotoxin  was  determined  by  a  neutralization  assay  and  percent  inhibition  was 
calculated  from  the  dose-response  curve  of cytotoxin  on  HeLa  cell  monolayers,  as 
previously described  (6). Enterotoxicity was assayed in  ligated rabbit  ileal  loops as the 
fluid volume/length ratio response (28),  and neurotoxicity was measured as the LDs0 in DONOHUE-ROLFE  ET  AL.  1771 
20-g Swiss-Webster  mice after  intraperitoneal  injection  of dilutions  of toxin  in  10  mM 
Tris-HCI, pH 7.4 (2). 
Results 
ShigeUa  Toxin  Purification.  Toxin  was  purified  from  a  total  cell  lysate  of 
washed early stationary phase S. dysenteriae  1, strain 60R. As a first step, we used 
chromatography on a column containing Blue Sepharose and salt (0.5 M) elution 
as described by Olsnes et al. (14). This step gave an initial 8-12-fold purification 
of toxin with a recovery of 80-90% of starting activity. Next, toxin was subjected 
to  chromatofocusing,  using  a  pH  gradient  of 8.3-6.  The  peak  of cytotoxic 
activity appeared at an eluate pH of 7.0-7.1  (Fig.  1), and resulted in a  100-fold 
purification with a  50-60%  yield of activity. The third and final step of this 
purification  was molecular sieve chromatography on  Bio-Gel P-60  to  remove 
minor protein contaminants as well as the ampholytes present in the chromato- 
focusing elution buffer. 
The yield and the increase in specific activity for each step in the purification 
is  shown  in  Table  I.  0.8  mg  of toxin  was  obtained  from a  3  liter  culture, 
representing a  final yield of ~50%  of initial cytotoxic activity. Fig.  2 shows an 
SDS-polyacrylamide gel electrophoresis analysis of the p( )tides obtained during 
each step of the purification scheme. After the Bio-Gel P-60  step,  two  major 
bands were observed (Fig.  2E), corresponding to molecular weights of 32,000 
and <10,000.  These two peptides have been found by others and have been 
referred to as the toxin A and B subunits, respectively (14).  In addition to the 
major subunits,  a  third  minor peptide  (Mr  28,000),  corresponding to  the A1 
fragment of the A subunit described by others (14,  15) was observed when the 
SDS gels were run under reducing conditions (Fig. 2E). 
Purified  shigella  toxin  was  cytotoxic  to  HeLa  cells  (3.4  x  107  TC~0  per 
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FIGURE  l.  Chromatofocusing of partially purified shigella toxin.  Fractions from the  Blue 
Sepharose salt elution containing protein were dialyzed against equilibration buffer and were 
chromatofocused as described in Materials and  Methods. The column flow rate was  9 ml/h 
and  1.5-ml fractions were collected. HeLa cell cytotoxicity was measured using a  10 -4 dilution 
of the fractions. Tubes 75-88 containing the peak of cytotoxin activity were pooled, concen- 
trated, and subjected to molecular sieve chromatography. 
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TABLE  I 
Purification of ShigeUa Toxin from a Whole Cell Lysate of S. dysenteriae 1 
Total  Cytotoxin  Increase in 
specific activity  specific  activity  Yield  Purification step  protein  (TCs0)  (fold) 
mg  % 
Cell lysate  2,300  2.5 ×  10  4  --  100 
Blue Sepharose eluate  165  3.0 x  10  ~  12  86 
Chromatofocusing,  1  3.1 x  107  1,240  54 
pH 7.1 peak 
Bio-Gel P-60  0.8  3.4 × 107  1,360  47 
FIGURE  2.  SDS-polyacrylamide  gel electrophoresis of the different stages of toxin purifica- 
tion. All samples were dissolved in SDS sample buffer containing 3-mercaptoethanol. Samples 
were heated in boiling water for 10 min before applying to a 15% acrylamide gel. (A) Whole 
cell lysate of S. dysenteriae 1  ; (B) Blue Sepharose flow-through; (C) Blue Sepharose salt eluate; 
(D) pI 7.1 region from the chromatofocusing step; (E) the final product after chromatography 
on Bio-Gel  P-60. The molecular weight standards (LKB)  were transferrin (MT 77,000), bovine 
serum albumin (Mr 66,000), ovalbumin (Mr 45,000), carbonic anhydrase (Mr 31,000), myoglo- 
bin (Mr 17,000), and cytochrome c (Mr 12,000). 
milligram protein [tissue culture LDs0 ratio]) and also possessed both neurotoxin 
and enterotoxin activities. In six rabbits tested, injection of >150 ng of purified 
toxin into ligated ileal loops resulted in  maximal  fluid accumulation of 1.8  ml/ 
cm  of ileum.  A  half-maximal  response was  obtained with  30  ng toxin.  During 
the  purification,  the  ratio  of cytotoxicity (TCs0)  to  enterotoxicity (maximum 
secretory dose) remained constant at  ~1,000:1.  Intraperitoneal  injection of 10 
ng of the purified toxin into mice resulted in the characteristic hind limb paralysis 
and neurotoxic death in 7 of 12 mice tested. 
Subunit  Composition.  To determine whether the two observed bands  associ- 
ated with one another and to investigate the actual subunit composition of the 
native  toxin,  we  carried  out  chemical  cross-linking  experiments.  We  used  the 
bifunctional  reagent  DMP  to  form  covalent complexes of the  subunits,  using 
~25I-labeled toxin (~30,000  cpm/ng)  to amplify the sensitivity of the detection 
procedure.  The cross-linked  products  were  separated  by  SDS-polyacrylamide 
gel electrophoresis and detected by autoradiography.  In addition to the 32,000 
and  <10,000  mol  wt  peptides,  a  series  of new  species  appeared  (Fig.  3).  The 
molecular weights of these peptides and their probable subunit composition are DONOHUE-ROLFE  ET  AL.  1773 
FIGURE 3.  SDS-polyacrylamide gel electrophoresis of cross-linked and non-cross-linked shi- 
gella toxin. 1251-labeled toxin was cross-linked as described in Materials and Methods in the 
absence of reducing agents. An autoradiogram of a  15%  acrylamide gel is shown. (A) l~sI- 
shigella toxin; (B) cross-linked iodinated toxin. The molecular weight markers (Bio Rad) were 
phosphorylase b  (Mr  92,000),  bovine serum albumin (Mr  66,000,  ovalbumin (M,  45,000), 
carbonic anhydrase (Mr 31,000)),  soybean trypsin inhibitor (Mr 21,000), and lysozyme (M, 
14,000). 
TABLE  II 
Molecular Weights and Tentative Composition of Cross-linked 
Complexes of Shigella Toxin 
Most probable 
Estimated Mr  subunit composition 
64,000  A +  5B 
57,000  A +  4B 
51,000  A +  3B 
45,000  A +  2B 
39,500  A +  1B 
32,000  A 
27,000  4B 
22,500  3B 
14,000  2B 
<10,000  B 
presented in  Table  II.  The lower molecular weight peptides are approximate 
multiples of 6,500, consistent with their being cross-linked dimers, trimers, and 
tetramers of the B subunit. Peptides >32,000 mol wt appear to be composed of 
the Mr  32,000  A  subunit  plus  multiples of 6,500,  suggesting that  they were 
derived by crosslinking the A  subunit with the monomer, dimer, trimer, tetra- 
mer, and pentamer of the smaller B subunit. We were unable to detect a separate 
band corresponding to a  B pentamer, probably because of the nearly identical 1774  PURIFICATION  AND  CHARACTERIZATION  OF  SHIGELLA  TOXIN 
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FIGURE  4.  Separation of toxin A and B subunits. ~51-1abeled toxin (6 x  10  5 cpm) was treated 
with 5% formic acid and the dissociated subunits were separated on a  Bio-Gel P-60 column as 
described in Materials and Methods. 
TABLE  III 
Amino Acid Compositions of the Subunits from Shigella Toxin 
Subunit A*  Subunit B * 
Amino acid  (residues/mol)  (residues/mol) 
Asp/Asn  33  10 
Thr  28  6 
Ser  30  2 
Glu/GIn  16  5 
Pro  7  1 
Gly  25  6 
Ala  21  2 
Val  22  5 
Met  7  1 
lie  16  3 
Leu  29  5 
Tyr  7  2 
Phe  16  4 
His  8  1 
Lys  4  5 
Arg  24  2 
* Based on estimated Mr of 32,000. 
* Determined  by  normalizing  the  values of methionine,  histidine,  and 
proline to one residue per mole. 
molecular weights of such a complex and the A  subunit.  We conclude that  the 
toxin  A  subunit  (Mr  32,000)  associates  with  five  B  subunits  (~Mr  6,500)  to 
produce the holotoxin of 64,000 mol wt. 
Separation  of A  and  B  Subunits.  Although  quantities  <100  ng/ml  of  125I- 
labeled  toxin  could  be  dissociated  into  A  and  B  subunits  with  10  M  urea, 
dissociation  was incomplete when  higher  concentrations  of toxin  (1-2  mg/ml) 
were used. However, an alternative procedure, treatment with 5% formic acid, 
was successful. Fig. 4 shows the gel filtration  profile of toxin dissociated in this 
manner.  Neither the isolated A  nor B subunits bound to HeLa cells, and they 
failed to cause measurable HeLa cell cytotoxicity (data not shown). The subunits DONOHUE-ROLFE  ET  AL.  1775 
FIGURE 5.  Immunoblots  of shigella toxin  demonstrating  subunit  specificity of the  rabbit 
polyclonal antibodies. Shigella toxin (10 #g/lane) was dissolved in SDS sample buffer without 
reducing agents. To increase the probability of detecting an antibody reaction with nondisso- 
ciated toxin A-B or B-B complexes, the samples were applied to a  15% acrylamide gel without 
prior heating. The protein t~'ansfer  and antibody treatment were performed as described in 
Materials and  Methods.  The immune reactions were detected by l*SI-labeled protein A and 
subsequent  autoradiograpby.  Lane  I,  rabbit  polyclonal antitoxin antibody;  lane 2,  purified 
rabbit  anti-B  subunit  antibody  eluted  from an  subunit  B-Sepharose  4B  column prepared 
from the antibody in lane A as described in Materials and Methods. 
TABLE  IV 
lmmunoglobulin Class and Iramunoprecipitation  Titer of Subunit-specific  Shigella  Toxin 
Antibodies 
Immunoglobu-  Subunit  lmmunoprecipi- 
Antibody  lin class*  specificity  tation titer* 
Monoclonal 5B2  IgG 1  A  1:800 
Monoclonal 5D2  IgG 1  A  1:1600 
Monoclonal 4D3  IgG 1  B  1:6400 
Rabbit antitoxin  --  A +  B  1:40000 
Rabbit anti-subunit  B  --  B  1:1600 
* hnmunoglobulin class was determined by Ouchterlony immunodiffusions in agarose using mouse 
isotype-specific antisera. 
* Immunoprecipitation titer was determined by measuring the dilution of antibody from which  10 
#1 immunoprecipitates >80% of added l~SI-labeled toxin (3 ×  104 cpm). 
FIGURE 6.  Immunoblots of shigella toxin demonstrating subunit specificity of two antitoxin 
monoclonal antibodies. The procedure was identical to that described in the legend to Fig. 5, 
except that toxin samples were heated in a boiling water bath for 10 min prio  r to application 
to  the  SDS-polyacrylamide  gel.  Lane  I,  rabbit  polyclonal  antibody;  lane  2,  mouse  5B2 
monoclonal antibody; lane 3, mouse 5D2 monoclonal antibody. 1776  PURIFICATION  AND  CHARACTERIZATION  OF  SHIGELLA TOXIN 
FIGURE  7.  Immunoblots of cross-linked.shigella toxin demonstrating subunit specificity of 
the mouse monoclonal antibody 4D3. Conditions were identical to those in Fig. 6 except that 
toxin was  cross-linked with  DMP  before SDS-polyacrylamide gel electrophoresis. Lane  I, 
rabbit polyclonal antibody; lane 2, mouse 4D3 monoclonal antibody. 
TABLE  V 
Neutralization of Cytotoxin by Polyclonal and Monoclonal Antibodies 
Subunit speci-  Percent 
Sample  Source of antibody  ficity of anti-  HeLa cell  toxin neu- 
body  mortality  tralization 
% 
Medium  --  --  0  -- 
Toxin  --  --  59.2  -- 
Toxin  Rabbit antitoxin  A +  B  34.1  >99 
Toxin  Rabbit anti-subunit B  B  30.0  >99 
Toxin  Monoclonal 5B2  A  34.0  >99 
Toxin  Monoclonal 5D2  A  29.7  >99 
Toxin  Monoclonal 4D3  B  11.8  >99 
Toxin,  1 ng/ml in McCoy's 5a modified medium, was preincubated at 37°C for  1 h with a  1:100 
dilution of rabbit polyclonal antitoxin, a  1:10 dilution of anti-subunit B rabbit antibody, or a  1:10 
dilution of ascites fluid from the hybridomas 5B2,  5D2, or 4D3. After preincubation, 0.2 ml of the 
antibody-toxin mixture was inoculated onto HeLa cell monolayers (20,000 cells) in duplicate wells of 
a 96-well tissue culture plate. After overnight incubation, cells remaining attached to the wells were 
counted and percentage mortality was calculated. The addition of a  1:100 dilution of normal rabbit 
serum or a  1:10 dilution of an unrelated ascites fluid had no toxin-neutralizing  activity. 
obtained  in  this  fashion  were  subjected  to  amino  acid analysis (Table  III).  No 
amino sugars were present in either subunit. 
Subunit Specificity of ShigeUa  Toxin Antibodies.  To  eliminate the  lethal effects 
of the  toxin,  we  immunized  animals  with  formalin  toxoid.  We  obtained  high 
titer polyclonal rabbit antiserum  capable of immunoprecipitating  toxin A  and B 
subunits  (Fig.  5  and  Table  IV).  B  subunit-specific  polyclonai  antibody  was 
purified  from  this  rabbit  serum  by  affinity  chromatography  as  described  in 
Materials  and  Methods.  The  immunoblot  analysis  with  this  purified  antibody 
(Fig. 5) demonstrates  that it binds only to complexes containing the B  subunit. 
We  isolated  three  monocional  neutralizing  antibodies against  shigella  toxin. 
Two  (5D2  and  5B2)  showed specificity by immunoblot  analysis for the  toxin A 
chain  (Fig.  6).  The  third  monoclonal,  4D3,  did not  react  with  either  the  A  or 
naonomeric B  subunit.  However,  when  the toxin subunits were cross-linked and 
subjected  to  immunobiot  analysis  using  the  4D3  antibody,  the  monocional 
reacted  with  all B  subunit-containing  complexes  but  not  with  the  B  monomer DONOHUE-ROLFE  ET  AL. 
TABLE  VI 
Ability of Antibodies to Neutralize Prebound Cytotoxin 
1777 
Subunit speci-  HeLa cell  Percent 
Sample  Source of antibody  ficity of anti-  mortality  toxin neu- 
body  tralization 
% 
Medium  --  --  0 
Toxin  --  --  55  -- 
Toxin  Rabbit antitoxin  A +  B  31.8  >99 
Toxin  Rabbit anti-subunit B  B  55  0 
Toxin  Monoclonal 5B2  A  45.5  90 
Toxin  Monoclonal 5D2  A  36.6  98 
Toxin  Monoclonal 4D3  B  54.7  6 
Toxin, antibody, and HeLa cell monolayers were all prechilled to 4°C. 0.2 ml of a  1 ng/ml solution 
of toxin was inoculated on HeLa cell monolayers in duplicate wells of a 96-well tissue culture plate. 
After a  1 h incubation at 4°C, the cell supernatants were removed and the cells washed three times 
with cold McCoy's medium. After removal of unbound toxin, 0.2 ml of each antibody diluted 1:10 
in the culture medium was added to the wells.  The cells were incubated at 4°C for  1 h  and then 
transferred to 37°C. The following day, the cells remaining attached to the wells were counted and 
the percentage mortality was calculated. No cytotoxin-neutralizing  activity was detected with either 
normal rabbit serum or with an unrelated ascites fluid. 
TABLE  VII 
Effect of Antibodies on Toxin Binding to HeLa Cell Monolayers 
Antibody subunit  cpm/10  ~ cells*  Percent 
Sample  specificity  inhibition 
Toxin  --  38,525  -- 
Toxin +  rabbit antitoxin  A +  B  2,480  94 
Toxin +  rabbit anti-  B  1,352  96 
subunit B 
Toxin +  5B2  A  14,895  61 
Toxin +  5D2  A  18,530  52 
Toxin +  4D3  B  855  98 
~2Sl-toxin (2 x  104 cpm,  1 ng) in McCoy's culture medium was incubated at 37°C for 1 h with a 
1:100 dilution of rabbit polyclonal antitoxin serum, with 1:10 dilution of the rabbit antisubunit B 
antibody or with a  1:10  dilution of the monoclonal antibodies. The toxin antibody mixtures (0.2 
ml) were then applied at 4°C to HeLa cell monolayers in duplicate wells of a 96-well tissue culture 
plate. The monolayers were incubated for 1 h at 4°C and then were washed twice with culture 
medium and three times with phosphate-buffered saline. The monolayers were then trypsinized 
and the number of cells per monolayer (~20,000) and radioactivity measured. 
* Corrected for the nonspecific binding of toxin to empty wells. 
(Fig.  7).  The  immunoglobulin  class  and  immunoprecipitating titers  of these 
antibodies are shown in Table IV. 
Neutralization  of Cytotoxicity by Antibody.  The ability of the polyclonal and 
monoclonal antibodies to neutralize cytotoxin activity was investigated in  two 
ways. In one set of experiments, toxin was preincubated at 37°C with antibody 
and then added to  HeLa cell monolayers. Cytotoxicity was measured after an 
overnight (16 h) incubation. All of the antibodies significantly (25-47%) reduced 
the observed HeLa cell mortality (Table V).  This represents neutralization of 
>99%  of added toxin activity, based on the dose-response curve in HeLa cells 1778  PURIFICATION  AND  CHARACTERIZATION  OF  SHIGELLA  TOXIN 
(21). The B subunit-specific monoclonal, 4D3, was the most effective neutraliz- 
ing antibody under these conditions. 
In the second set of experiments,  toxin was added to cells prechilled to 4°C. 
After a  1 h incubation at 4°C to permit binding but not internalization  of toxin, 
antibody  was added  and  incubated  for  1  h  in  the  cold.  The  cells were  then 
warmed  to  37°C  and  cytotoxicity was measured.  Under these  conditions,  the 
polyclonal rabbit antitoxin and both A-specific monoclonals, 5D2 and 5B2, were 
significantly neutralizing  (Table VI).  In  contrast,  neither  of the two B-specific 
antibodies,  the  monoclonai  4D3  and  the  purified  rabbit  anti-subunit  B  poly- 
clonal, were able to neutralize the prebound toxin. The effect of these antibodies 
on binding of ~25I-toxin  to HeLa cell monolayers is shown in Table VII. All B 
subunit-specific reagents inhibited the binding of toxin to the HeLa cell by 94% 
or more. In contrast, the two antibodies with A subunit specificity, 5B2 and 5D2, 
were much less effective, reducing toxin binding by ~50%. 
Discussion 
In this paper we present a simple, rapid, high-yielding purification scheme for 
shigella toxin.  In addition to cytotoxin activity, the purified toxin also possessed 
potent neurotoxin  and  enterotoxin  properties.  The  cytotoxin and  enterotoxin 
activities copurified, as determined by the ratio of their specific activities.  This 
adds to the evidence that one toxin molecule is responsible for all three biological 
activities. 
On SDS-polyacrylamide gels, the purified toxin consisted of two major com- 
ponents,  an  A  chain  of 32,000  mol  wt and a  B chain  of <10,000  mol wt.  To 
investigate  the  subunit  stoichiometry,  we used  the  bivalent reagent,  DMP,  to 
cross-link  the  toxin  subunits.  Analysis  of the  cross-linked  complexes by SDS- 
polyacrylamide gel electrophoresis revealed four distinct complexes of molecular 
weight  less  than  that  of the  isolated  A  chain.  These  are  consistent  with  the 
position of monomeric, dimeric,  trimeric,  and tetrameric forms of the B chain, 
with molecular weights that were approximate multiples of 6,500.  Five discrete 
complexes of >32,000 mol wt were present, also in molecular weight increments 
of ~6,500.  These clearly represent  the  formation  of A-B,  A-2B, A-3B, A-4B, 
and A-5B complexes. Since a  complex of five cross-linked B monomers would 
be expected to have a molecular weight of 32,500 (5 x  6,500), it is unlikely that 
it would have been distinguished  on SDS gels, being obscured by the A  chain 
itself at M, 32,000. On this basis, we propose that shigella toxin is composed of 
one A subunit linked to five B subunits, with a molecular weight of 64,000. 
The proposed  1A-5B structure differs slightly from that reported by others. 
Olsnes  et al.  (14)  suggested  that  shigella  toxin  consists  of one  A  subunit  (M, 
30,500) and six or seven B subunits (M, 5,000).  O'Brien and  LaVeck (9) have 
reported  that  the  toxin  is composed of one A  subunit (M,  31,500)  and  six  or 
possibly more B subunits (M, 4,000). These discrepancies are probably due to an 
underestimate of the molecular weight of the B monomer. Further evidence that 
the molecular weight of the toxin B chain is at least 6,500 can be obtained from 
the amino acid analysis of the B chain.  Normalizing  the values of methionine, 
histidine, and proline to one residue per B monomer resulted in the amino acid 
composition seen in Table II.  Based on this composition, the molecular weight DONOHUE-ROLFE  ET  AL.  1779 
of the B subunit would be 6,690. Since the number of cysteines and tryptophans 
was not assessed, this estimated molecular weight must be considered a  lower 
limit. 
Most well-studied toxins conform to a general A-B structural model in which 
the molecules can be separated into an A domain responsible for the biological 
activity of the toxin and a B domain mediating the binding of toxin to the target 
cell surface. Reisbig et al. (16) have demonstrated that the A chain of shigella 
toxin inhibits protein synthesis in vitro, and we have confirmed these data with 
toxin purified by the method described in this paper (unpublished data). These 
studies also provide the first evidence that the B subunit is involved in binding 
to the cell membrane of sensitive HeLa cell targets. We have investigated the 
effects of subunit-specific antisera on both cytotoxin neutralization and binding. 
A  and  B  subunit-specific  antibodies  neutralized  the  toxin  when  incubated 
together before addition to  HeLa cell monolayers. In contrast,  when shigella 
toxin  was  preincubated with  HeLa  cells at  4°C  to  allow  binding  to  the cell 
surface but  not  internalization  (29,  30),  the  subsequent  addition  of antisera 
resulted in  neutralization only when there were A  subunit-specific antibodies 
present.  When  antibodies  directed exclusively to  the  B  subunit  were  used, 
including a monoclonal antibody (4D3) and a polyclonal rabbit antiserum, there 
was no neutralization of prebound toxin. This clearly suggests that anti-B subunit 
antibodies are directed to a binding domain of the toxin. This hypothesis was 
directly confirmed by assessing the ability of these sera to inhibit binding of 125I- 
toxin to HeLa cell monolayers. Anti-B subunit sera inhibited binding by 94% 
or more, whereas A subunit-specific antibodies reduced binding by -50%. The 
reasons for this latter result are not certain, but are likely the consequence of 
kinetic differences in the binding of free toxin compared with toxin-antibody 
complexes. The data are therefore most consistent with the involvement of the 
B subunit in receptor binding. They further suggest that antibodies against the 
B subunit, whether polyclonal or monoclonal, neutralize shigeUa toxin by pre- 
venting its binding to the HeLa cell surface. Once toxin is bound to the cell 
surface, only antibody against the A subunit is effective. 
These studies have clarified the roles of the A and B subunits of shigella toxin 
as the biologically active (A) and binding (B) subunits.  The availability of the 
purified subunits and subunit-specific antibodies should now facilitate studies to 
define the mechanism of action of the A subunit as well as the basis of the binding 
specificity of the B subunit. 
Summary 
A  simple purifcation scheme for shigella cytotoxin was devised, resulting in 
high yields (~50%) and a  1,300-fold increase in specific activity compared with 
the initial crude bacterial cell lysate. The purified toxin was enterotoxic in ligated 
rabbit ileal loops and neurotoxic when injected into the peritoneal cavity of mice. 
Measurement of specific activity of cytotoxin and enterotoxin demonstrated that 
these two toxicities copurify during the fractionation procedure. 
On  sodium  dodecyl sulfate  gel  electrophoresis,  the  toxin  migrated as  two 
polypeptide subunits, an A subunit of 32,000  mol wt and a  B subunit of 6,500 
tool  wt.  Chemical  cross-linking  experiments demonstrate  that  the  toxin  is  a 1780  PURIFICATION  AND  CHARACTERIZATION  OF  SHIGELLA TOXIN 
complex consisting  of one  A  and  five  B  subunits  with  a  molecular  weight  of 
64,000. 
Polyclonal rabbit anti-toxin and anti-subunit B antisera were produced as well 
as  subunit-specific  mouse  monoclonal  antibodies.  All  antibodies  preincubated 
with  toxin  neutralized cytotoxic effects in  HeLa cell  monolayers.  In  contrast, 
only A subunit-specific antibodies were able to neutralize toxin prebound to the 
HeLa  cell  surface.  Antibody  to  the  B  subunit  also  inhibited  binding  of 1251- 
labeled toxin to these cells by 94% or more. These data demonstrate that the B 
subunit is involved in shigella toxin binding to the cell surface. 
Received for publication 20 August 1984. 
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